Alpha Tau Medical (DRTS) Preferred Stock Liabilities (2020 - 2026)

Alpha Tau Medical has disclosed Preferred Stock Liabilities across 7 years of filings, most recently posting $15.7 million for Q1 2026.

• Preferred Stock Liabilities for Q1 2026 came in at $15.7 million, up 344.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.7 million (up 344.23% YoY), and the FY2025 annual result was $5.4 million, up 60.4% from the prior year.
• Preferred Stock Liabilities came in at $15.7 million for Q1 2026 at Alpha Tau Medical, up from $5.4 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $18.8 million in Q1 2022 to a low of $3.3 million in Q4 2024.
• The 5-year median for Preferred Stock Liabilities is $5.4 million (2025), against an average of $6.9 million.
• Across the five-year window, Preferred Stock Liabilities slumped 69.77% in 2022 and jumped 344.23% in 2026, its largest moves.
• Alpha Tau Medical's Preferred Stock Liabilities stood at $5.6 million in 2022, then sank by 36.11% to $3.6 million in 2023, then decreased by 7.2% to $3.3 million in 2024, then soared by 60.4% to $5.4 million in 2025, then surged by 194.14% to $15.7 million in 2026.
• The last three Preferred Stock Liabilities figures came in at $15.7 million (Q1 2026), $5.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.